Missouri Offers Free Vaccinations for Whooping Cough.


What do you do when you are offered something free? If you’re like most people, you accept it, oftentimes when it’s something you will never use or don’t even like. So, when a state offers free vaccines, those with limited knowledge of their negative effects may begin lining up. Unfortunately, flu season is approaching, so millions will line up for this questionable anti-flu solution.

That’s the concern of Michelle Goldstein at VacTruth.com. Goldstein reports on a recent incidence in Missouri, where state officials launched a propaganda campaign aimed at vaccinating as many in the state as possible, by offering free Tdap vaccines in the St. Louis area.

The “giveaway” was recently announced in St. Louis, where the paper announced that incidence of whooping cough have risen to levels not seen since 1955, due in part because vaccinations given more than 10 years ago were wearing off. Last year, more than 41,000 cases of pertussis were reported nationwide; this is in contrast to 18,719 cases the year before.

vaccine_fast-263x164

While St. Louis Today and the Missouri Department of Health are quick to point out all of the scary effects of whooping cough, they neglect to discuss the scary effects of the Tdap vaccine and the fact that pertussis can be effectively treated without conventional pharmaceutical means.

According to Goldstein:

“Health consequences resulting from the Tdap vaccine include encephalitis, brain damage and death. A comprehensive report made by the National Vaccine Information Center (NVIC) documents clearly the widespread health dangers associated with the Tdap vaccine. Tdap and DTap vaccines are currently used in the United States, replacing the DTP vaccine in 1996, but all three vaccines contain the dangerous pertussis toxin with unsafe additives.”

Exposing the Vaccination-Immunity Fraud

Also interesting, most of those who have recently contracted pertussis were actually vaccinated at some point. In other words, while there is solid proof of the vaccinations causing harm, there is no solid evidence that it can definitively prevent the disease.

In addition, whopping cough can be treated without prescription drugs. As a matter of fact, a successful bout of pertussis means lifelong immunity. In other words, once you have it you won’t get it again. What’s the most effective treatment for whooping cough? A vitamin C protocol that can dramatically reduce symptoms and complications.

Finally, the other conditions this Tdap vaccine “protects” against—tetanus and diphtheria—are not only uncommon in the U.S., but can similarly be prevented and treated with risk of complications being relatively low.

Since whooping cough can be problematic for young children, it’s important to do whatever you think is best as a parent; it’s just important to know truths behind the chosen solution.

Whooping Cough Vaccine Can Cause Brain Damage And Death.


 In July, the state of Missouri began offering for free a vaccine aimed at preventing, among other ailments, whooping cough. According to officials, the TDap vaccine, which reportedly prevents tetanus, diphtheria and pertussis, was necessary because “of the rising incidence of whooping cough is reported to be related to the vaccine wearing off if given more than ten years earlier,” says an online report.

Citing a St. Louis Post Dispatch article, Michelle Goldstein of VacTruth.com says some 41,000 cases of pertussis occurred in the U.S. in 2012, compared to less than 19,000 cases in the previous year – thus the need for the new vaccine.

“The news story emphasized that whooping cough is highly dangerous and can lead to vomiting and death, especially in children. The report indicates that diphtheria is a bacterial disease that is highly contagious and can also lead to death,” Goldstein writes, adding that tetanus can cause severe muscle spasms.

Natural remedies, treatments can work without risk

What the paper failed to report, however, is that there are serious health risks associated with the Tdap vaccines. Also, there are relatively benign health implications that are commonly associated with the diseases the vaccine is intended to prevent – “along with the important fact that vaccines have never been proven to prevent any disease,” Goldstein said.

She adds:
The risks that WHOOPING COUGH, diphtheria and tetanus pose to health are low compared to the potential, serious dangers reported as a result of this vaccine. Whooping cough can be treated successfully through a vitamin C protocol developed by Dr. Suzanne Humphries which has been shown to greatly reduce symptoms. In contrast, antibiotic treatments, given routinely by conventional, allopathic physicians to treat whooping COUGH, have never been shown to positively impact the course of the illness.
Whatever the standard medical treatments, most people fully recover from whooping cough, which then gives them lifetime immunity from it. If they should become re-infected, Goldstein writes, subsequent episodes are generally “quite mild.”

Meanwhile, tetanus can be prevented in a number of ways without ever receiving a VACCINE. For instance, simply thoroughly washing and cleaning cuts can prevent the disease. And in actuality, contracting the disease in the first place is rare; just “233 cases of tetanus were reported to the Center for Disease Control between 2001 and 2008,” Goldstein points out, citing the federal agency’s own figures. “The incidence of tetanus declined by more than 95% between 1947 and 2008.”

Finally, diphtheria is also a low-risk disease, and one that is not seen widely in the U.S. since an outbreak in the 1970s. Over the 30-year period between 1980 and 2010, just 55 cases of the disease were reported to the CDC.

Vaccine dangers outweigh risk of actually getting the disease

The dangers of getting a Tdap vaccine can also be significant. According to Goldstein:

Health consequences resulting from the Tdap vaccine include encephalitis, BRAIN DAMAGE and death. A comprehensive report made by the National Vaccine Information Center (NVIC) documents clearly the widespread health dangers associated with the Tdap vaccine. Tdap and DTap vaccines are currently used in the United States, replacing the DTP vaccine in 1996, but all three vaccines contain the dangerous pertussis toxin with unsafe additives.

Furthermore, experts note, the fact that whooping cough even occurs in “vaccinated” populations is a sign that vaccines are not effective at preventing the disease.

Sources: Raw For Beauty

 

Effectiveness of pertussis vaccines for adolescents and adults: case-control study.


Abstract

Objective To assess the effectiveness of reduced acellular pertussis (Tdap) vaccines in adolescents and adults.

Setting Kaiser Permanente Northern California.

Design Case-control study.

Participants All polymerase chain reaction (PCR) confirmed cases of pertussis in members aged 11 years and older from January 2006 to December 2011. We compared the Tdap vaccination status of PCR positive cases with two control groups: people testing negative for pertussis by PCR and closely matched people from the general Kaiser Permanente Northern California population.

Main outcome measure PCR confirmed pertussis. The association of Tdap vaccination with the odds of pertussis infection was estimated by conditional logistic regression, with adjustment for calendar time, pertussis vaccine type received in early childhood, age, sex, race or ethnic group, and medical clinic. We calculated Tdap vaccine effectiveness as 1 minus the adjusted odds ratio.

Results The study population included 668 PCR positive cases, 10 098 PCR negative controls, and 21 599 Kaiser Permanente Northern California matched controls. Tdap vaccination rates were 24.0% in PCR positive cases and 31.9% in PCR negative controls (P<0.001). The adjusted estimate of effectiveness of Tdap vaccination against pertussis was 53.0% (95% confidence interval 41.9% to 62.0%) in the comparison with PCR controls, and 64.0% (55.5% to 70.9%) in the comparison with Kaiser Permanente Northern California controls.

Conclusion Tdap vaccination was moderately effective at preventing PCR confirmed pertussis among adolescents and adults.

 

Discussion

We found that tetanus toxoid, reduced diphtheria toxoid, and reduced acellular pertussis (Tdap) vaccination was moderately effective at preventing pertussis in people aged 11 years and older during a study period that included the large outbreak in California in 2010 and 2011. Tdap vaccination was estimated to reduce the risk of polymerase chain reaction (PCR) confirmed pertussis in our study population by 53% (95% confidence interval 42% to 62%) in the comparison with PCR negative controls and by 64% (56% to 71%) in the comparison with Kaiser Permanente Northern California controls. Both estimates of vaccine effectiveness and the range covered by their confidence intervals indicate that Tdap vaccination was moderately protective against pertussis.

In subgroup analyses, we found that the Tdap booster was moderately effective both in older people who had received all whole cell pertussis vaccines as infants and in younger people who had received all acellular pertussis vaccines. Yet, rates of pertussis were highest in the acellular subgroup consisting of young adolescents ages 11-14, probably because protection from their childhood doses waned substantially over time.13 30 As a result, the absolute benefit of Tdap vaccination was much greater for people who had received acellular instead of whole cell vaccines as children. Strategies to decrease the incidence of pertussis should prioritize giving the Tdap booster to people who received only acellular pertussis vaccines as children, as California has done since the 2010 outbreak, requiring Tdap vaccination for middle school students. To our knowledge this is the first study to assess the effectiveness of the Tdap booster in members of this new generation that has received all acellular vaccines.

We had limited power to assess the effectiveness of Tdap vaccines in the subgroup of people born before 1950. The confidence interval suggests that effectiveness was unlikely to be higher than 68%. This subgroup was at low risk of pertussis, perhaps as a result of immunity conferred by natural infection, receipt of single antigen whole cell vaccines available before the whole cell pertussis combination vaccines, or less frequent contact with infected people; this subgroup also had low Tdap vaccination coverage, since it was not until 2012 that the US Advisory Committee on Immunization Practices recommended routine Tdap vaccination for people aged 65 years and older.

Prior post-licensure studies of Tdap vaccine effectiveness have been limited by low numbers of cases. One controlled study showed vaccine effectiveness of 92% (95% confidence interval 32% to 99%) in preventing clinical pertussis,21but there were only 10 people who met the definition of a primary case. More recently, another study investigating a pertussis outbreak in the US Virgin Islands found vaccine effectiveness of 66%22 in an analysis of 51 confirmed or probable pertussis cases. An observational study from Australia23 evaluating a mass vaccination program for high school students, found vaccine effectiveness of 78.0% (95% confidence interval 60.7% to 87.6%) based on 167 cases.

Source: BMJ

Vaccines for adults: Which do you need?


Vaccines offer protection from various types of infections and diseases, from seasonal flu to diphtheria. Understand which vaccines adults need and when to get them.

Wonder which vaccines you need? It can be confusing, especially if you thought vaccines were just for kids. Use the list below to find out which vaccines you need now and which vaccines might be coming up — based on recommendations from the Centers for Disease Control and Prevention.

Seasonal influenza (flu)

Seasonal flu is a viral infection that affects the respiratory system. Potentially serious — even life-threatening — complications of the flu are possible.

Who needs it
The flu vaccine is recommended for all adults — unless you had a severe reaction to a previous flu vaccine or you’re currently ill. The flu vaccine is available as a shot or a nasal spray.

If you’re pregnant, choose the flu shot vaccine — not the nasal spray vaccine. If you’re age 65 or older, ask your doctor about a high-dose flu shot. Consult your doctor before getting a flu vaccine if you’ve had Guillain-Barre syndrome or you have a severe allergy to eggs.

When to have it
Get one dose of the flu vaccine every year, ideally in September or as soon as the vaccine is available.

Pneumococcal disease

Pneumococcal disease is a potentially serious infection caused by a type of bacteria called pneumococcus. Pneumococcal disease can take various forms, including pneumococcal pneumonia and pneumococcal meningitis. Pneumococcus also causes infections in the bloodstream.

Who needs it
Get the pneumococcal polysaccharide vaccine — the type of pneumococcal vaccine available for adults — if:

  • You’re age 65 or older
  • You have a weak immune system
  • You have a chronic illness, including asthma, lung disease, liver disease or diabetes
  • You’ve had your spleen removed
  • You live in a long term care facility
  • You smoke

Don’t get the vaccine if you had a severe reaction to a previous dose of the vaccine or you’re currently ill.

When to have it
Get one dose of the pneumococcal vaccine at any time. Ask your doctor if you need a second dose.

Tetanus, diphtheria and pertussis

Tetanus, diphtheria and pertussis are bacterial infections. Tetanus, sometimes called lockjaw, affects the nervous system, leading to painful muscle contractions — especially in the jaw and neck. Diphtheria is a respiratory disease that can lead to difficulty breathing. Whooping cough (pertussis) causes cold-like signs and symptoms and a persistent hacking cough.

Who needs it
Get the combined tetanus toxoid, reduced diphtheria and acellular pertussis (Tdap) vaccine if you haven’t received the vaccine in the past or don’t know if you’ve received the vaccine.

The Tdap vaccine isn’t recommended if you had a severe reaction to a previous dose of the tetanus-diphtheria (Td) series or Tdap vaccine, you experienced a coma or seizures within seven days of a previous dose of the vaccine or you’re currently ill. Consult your doctor before getting the Tdap vaccine if you have epilepsy or you’ve had Guillain-Barre syndrome.

When to have it
Get one dose of the Tdap vaccine if you didn’t finish the Td series as a child or don’t know if you ever had the Td vaccine. Get a second dose four weeks after the first dose. Get a third dose six to 12 months after the second dose.If you’re due for a Td booster — recommended every 10 years — but haven’t previously received Tdap, get one dose of the Tdap vaccine at any time followed by a Td booster every 10 years.

Meningitis

Meningitis is an inflammation of the membranes surrounding the brain and spinal cord.

Who needs it
Get the meningitis (meningococcal) vaccine if:

  • You didn’t have the vaccine as a child or adolescent and you’re living in a dormitory for the first time
  • You travel to or work in parts of the world where meningitis is common
  • You’re joining the military
  • You had your spleen removed
  • A meningitis outbreak occurs in your community

The meningitis vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine or you’re currently ill.

When to have it
Get one dose of the meningitis vaccine at any time — or a booster dose if you’re a first-year college student up to age 21 and first had the vaccine before age 16. Get a second dose eight weeks later if you have certain health conditions, such as HIV.

Chickenpox (varicella)

Chickenpox is a highly contagious infection that causes a red, itchy rash. Complications can include a bacterial infection of the skin, an infection in the bloodstream, pneumonia or inflammation of the brain (encephalitis).

Who needs it
Get the chickenpox vaccine if:

  • You didn’t have the vaccine as a child or adolescent or you’ve never hadchickenpox — especially if you live with someone who has a weak immune system
  • You aren’t sure whether you’ve had chickenpox
  • You’re considering pregnancy and don’t know if you’re immune to chickenpox

The chickenpox vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine or to gelatin or the antibiotic neomycin, you’re currently ill, you’re pregnant or you have a weak immune system.

When to have it
Get one dose of the chickenpox vaccine at any time. Get a second dose at least four weeks after the first dose.

Measles, mumps and rubella

Measles, mumps and rubella are viral infections. Measles causes a red, blotchy skin rash. Complications can include ear infection, pneumonia and inflammation of the brain (encephalitis). Mumps causes swelling in the salivary glands, located below and in front of your ears. Rubella, also called German measles, causes a distinctive red rash. Rubella is most serious if it develops during pregnancy.

Who needs it
Get the combined measles-mumps-rubella (MMR) vaccine if you were born during or after 1957 and didn’t have the vaccine as a child or adolescent.

The MMR vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine or to gelatin or the antibiotic neomycin, you’re currently ill, you’re pregnant, you have a weak immune system, or you recently had a blood transfusion.

When to have it
Get one dose of the MMR vaccine at any time. Get a second dose at least four weeks after the first dose if you’re a health care worker, you travel internationally, you’re a college student, or you had a rubella blood test that shows no immunity.

Human papillomavirus

Genital human papillomavirus (HPV) is a common sexually transmitted infection. Most people who have HPV don’t develop symptoms. For some people, however, an HPV infection can lead to genital warts or, for women, cervical cancer.

Who needs it
Get the human papillomavirus (HPV) vaccine if:

  • You’re a woman age 26 or younger and didn’t have the vaccine as an adolescent
  • You’re a man age 21 or younger and didn’t have the vaccine as an adolescent — although men can get the vaccine through age 26, if desired

The HPV vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine, you have a severe allergy to yeast or latex, you’re pregnant, or you’re currently ill.

When to have it
Get one dose of the HPV vaccine at any time. Get a second dose one to two months after the first dose, and a third dose six months after the first dose.

Hepatitis A

Hepatitis A is a potentially serious liver infection.

Who needs it
Get the hepatitis A vaccine if:

  • You want to protect yourself from hepatitis A
  • You have a clotting-factor disorder or chronic liver disease
  • You’re a man who has sex with men
  • You inject illicit drugs
  • You’re a health care worker who might be exposed to hepatitis A in a lab setting
  • You travel to or work in parts of the world where hepatitis A is common

The hepatitis A vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine, you have a severe allergy to latex or you’re currently ill.

When to have it
Get one dose of the hepatitis A vaccine at any time. Get a second dose six at least six months after the first dose.

Hepatitis B

Hepatitis B is another type of liver infection. For some people, hepatitis B becomes chronic — leading to long-term liver problems.

Who needs it
Get the hepatitis B vaccine if:

  • You want to protect yourself from hepatitis B
  • You’re sexually active but not in a mutually monogamous relationship
  • You’re a man who has sex with men
  • You have close contact or sex with a person infected with hepatitis B
  • You inject illicit drugs
  • You’re receiving hemodialysis
  • You’re a health care or public safety worker who might be exposed to infected blood or body fluids
  • You live with someone who has a chronic hepatitis B infection
  • You travel to or work in parts of the world where hepatitis B is common
  • You’re age 59 or younger and have type 1 or type 2 diabetes and haven’t received the hepatitis B vaccine

If you’re age 60 or older and have diabetes, ask your doctor if the hepatitis B vaccine is right for you. The hepatitis B vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine, you have a severe allergy to yeast or you’re currently ill.

When to have it
Get one dose of the hepatitis B vaccine at any time. Get a second dose one month after the first dose. Get a third dose at least two months after the second dose and at least four months after the first dose.

Shingles (herpes zoster)

Shingles is a viral infection that causes a painful rash. Anyone who has recovered from chickenpox might eventually develop shingles.

Who needs it
Get the shingles vaccine if you’re age 60 or older.

The shingles vaccine isn’t recommended if you’re currently ill, you had a severe reaction to gelatin or the antibiotic neomycin, you have a weak immune system or you’re pregnant.

When to have it
Get one dose of the shingles vaccine at any time.

Haemophilus influenzae type b (Hib)

Hib is a bacterium that causes potentially serious infections, including pneumonia, meningitis and swelling of the piece of cartilage that covers the windpipe (epiglottitis).

Who needs it
Get one dose of the Haemophilus influenzae type b (Hib) vaccine if:

  • You have certain health conditions, such as sickle cell disease, leukemia or HIV
  • You had your spleen removed

The Hib vaccine isn’t recommended if you had a severe reaction to a previous dose of the vaccine or you’re currently ill.

When to have it
Get one dose of the Hib vaccine at any time.

Source: Mayo Clinic.